IP Library › Granted Patent US 6,875,587
Granted Patent B2
US 6,875,587 · App. 10/419,277 · Granted Apr 5, 2005

Human protease inhibitor and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,875,587
App. No.
10/419,277
Granted
Apr 5, 2005
Kind
B2
Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications

Claims (5)

1. A host cell comprising an expression vector comprising a nucleic acid sequence that encodes the amino acid sequence of SEQ ID NO:2.

2. The host cell of claim 1 wherein said nucleic acid sequence is that of SEQ ID NO: 1.

3. A method of producing a protein, comprising culturing the cell of claim 1 under conditions permitting expression of the polypeptide.

4. A method of producing a protein, comprising culturing the cell of claim 2 under conditions permitting expression of the polypeptide.

5. An expression vector comprising the nucleic acid sequence of SEQ ID NO: 1.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →